Changes in Beneficial Ownership · 4
VERTEX PHARMACEUTICALS INC / MA
VRTXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1788207608.xml
Filing details
- Report period
- 2026-08-27
- Issuer
- VERTEX PHARMACEUTICALS INC / MA
- Issuer CIK
- 0000875320
- Trading symbol
- VRTX
Reporting owner 1
- Name
- SACHS BRUCE I
- Reporting owner CIK
- 0001197036
- Relationship
- Director
- Address
- C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVE, BOSTON, MA, 02210
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-27 | G · Form 4 | 6,000 | D | 0 | 39,000 | D |
Table key
- G · Form 4
- Bona fide gift
- D
- Direct
Signature 1
- Signed
- /s/ Christiana Stevenson, Attorney-in-Fact
- Date
- 2026-08-31
Company context
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America, and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 16 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex’s history of innovation, visit at www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 20, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 1, 2026
- 144 filingAug 27, 2026
- 10-Q filingAug 4, 2026
- Results of Operations and Financial ConditionAug 3, 2026